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Soluble prion protein makes mice unsteady.
Lindquist/AAAS version: the infectious, detergent-resistant, plaque-forming fibrillar PrP
Sc seen in diseased brains of scrapie-infected sheep and mad cows. Instead, Jiyan Ma, Robert Wollmann (University of Chicago, Chicago, IL), and Susan Lindquist (MIT, Cambridge, MA) point the finger at cytosolic PrP.
Minor misfolding events probably lead to continual ejection of PrP from the ER into the cytosol for degradation by proteasomes. The team's inhibition of cytosolic proteasomes preferentially killed cells expressing PrP, and expression of PrP lacking ER translocation signals was highly toxic to neural cells both in vitro and in vivo. Transgenic mice producing cytosolic PrP suffered from unsteady gait and massive neuronal loss due to degeneration rather than problems in development. Thus, a cytosolic PrP rather than extracellular PrP Sc aggregate appears to be the toxic species.
"This represents a real breakthrough in the prion field," says Peter Lansbury (Harvard Medical School, Boston, MA). At the same time, he says, "I'm not at all surprised. It's very consistent with all the other neurodegenerative diseases." Fibrillar forms of ␤ -amyloid (in Alzheimer's disease) and
Transcriptional segregation
acterial genetics was meant to be easy. But, genetics or no genetics, the identity of the motor for segregating bacterial DNA remained a mystery. "People should have found it," says Jonathan Dworkin. "It's something that is relatively easy to score for."
Dworkin and Richard Losick (Harvard University, Cambridge, MA) now claim that the motor has never been found before because it is RNA polymerase. "You use a common mechanism to drive B
[segregation]-we like the parsimony of that," says Dworkin. "But one of the things that is appealing about the model also makes it difficult to test"-and impossible to discover by genetics.
Dworkin and Losick have tested the model by direct chemical inhibition of RNA polymerase. They found that the segregation of bacterial chromosomes ␣ -synuclein (in Parkinson's disease) initially dominated theories of pathogenesis in these neurodegenerative conditions. But others have demonstrated extraordinary toxicity of microinjected ␤ -amyloid protein, and Lansbury has pointed to cytoplasmic protofilaments-a non-plaque form that resemble pore-forming bacterial toxins-as the toxic species.
The prion field, however, has assumed that the infectious aggregates of PrP Sc are also the toxic form. "The whole field has been driven by neuropathology," says Lansbury. "That's why it's so good to have people from different backgrounds working on this.
[Lindquist] isn't subject to the years and years of focus on amyloid plaques." The Lindquist team also showed that proteasome inhibition could eventually lead to formation of PrP Sc . Lindquist suggests that the toxicity of cytosolic PrP may be a way of sabotaging this event. In this theory, if folding problems lead to excessive ejection of PrP from the ER to the cytosol, the cell commits suicide rather than risk making the infectious version, PrP Sc . Cytosolic PrP, says Lindquist, "is so extremely toxic that it may represent a defense mechanism." slows drastically, even though a translation inhibitor has no such effect. This transcription dependence holds true even if replication restarts from a starvationinduced pause. The researchers imagine that back-toback DNA polymerase machines at the origin of replication get the two DNA molecules headed off in opposite directions. But this motor is unlikely to sustain lengthy linear movement, as DNA is too flexible to be pushed successfully from one end. This is where RNA polymerase comes in. The enzyme, which is known to exert greater than five times more force than myosin, is thought to be tethered by its sheer size or its attachment to ribosomes. The directionality of force comes from genome organization. Two-thirds of genes are transcribed in the direction of replication (away from the origin of replication), and up to 75% of transcription involves rRNA genes, all of which point away from the origin. Thus, successive RNA polymerase complexes should spool DNA away from the center of the cell.
"It's difficult to do experiments that are clean," says Dworkin. "We do feel cautious about [the model]." But he notes a pattern that supports the model. Nearly all surviving large DNA rearrangements are almost symmetrical about the origin of replication, thus retaining the directional bias of transcription. The one known exception has a severe defect in chromosome segregation. Dworkin now plans to test whether this is a fluke or a general rule by engineering multiple origin-asymmetric rearrangements using recombinases. If the theory stands, this may be the original and most direct way of coupling growth (transcription levels) with segregation, and thus division.
